The 80th Annual Meeting of the Japanese Society of Hematology

Presentation information

Poster Session

Fri. Oct, 12

Poster Session 1-12 MalignantLynphoma: Pathophysiology/Others

Fri. Oct 12, 2018 5:50 PM - 6:30 PM Poster1 (Osaka International Convention Center, 3F Event Hall)

Chair: Toshiki Uchida (Department of Hematology and Oncology, Japanese Red Cross Nagoya Daini Hospital)

[PS1-12-4] Recent approval status for anti-hematologic malignancy drugs including anti-lymphoma drugs

Chikara Hirase1, Ken Hatogai2, Yuka Kato3 (1.Clinical Research Center, Kindai Univ. Hospital, Osaka, Japan, 2.National Cancer Center Hospital East, Chiba, Japan, 3.Pharmaceuticals and Medical Devices Agency, Tokyo, Japan)

Abstract password authentication.
Password is written on a program and abstract book.

Password